These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23705996)

  • 21. Pluripotent human stem cells for the treatment of retinal disease.
    Rowland TJ; Buchholz DE; Clegg DO
    J Cell Physiol; 2012 Feb; 227(2):457-66. PubMed ID: 21520078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins.
    Rowland TJ; Blaschke AJ; Buchholz DE; Hikita ST; Johnson LV; Clegg DO
    J Tissue Eng Regen Med; 2013 Aug; 7(8):642-53. PubMed ID: 22514096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concise Review: Making Stem Cells Retinal: Methods for Deriving Retinal Pigment Epithelium and Implications for Patients With Ocular Disease.
    Leach LL; Clegg DO
    Stem Cells; 2015 Aug; 33(8):2363-73. PubMed ID: 25809736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stem cell therapies for age-related macular degeneration: the past, present, and future.
    Dang Y; Zhang C; Zhu Y
    Clin Interv Aging; 2015; 10():255-64. PubMed ID: 25609937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of human embryonic stem cell therapies for age-related macular degeneration.
    Carr AJ; Smart MJ; Ramsden CM; Powner MB; da Cruz L; Coffey PJ
    Trends Neurosci; 2013 Jul; 36(7):385-95. PubMed ID: 23601133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utilizing stem cell-derived RPE cells as a therapeutic intervention for age-related macular degeneration.
    Westenskow PD; Kurihara T; Friedlander M
    Adv Exp Med Biol; 2014; 801():323-9. PubMed ID: 24664714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A method to enhance cell survival on Bruch's membrane in eyes affected by age and age-related macular degeneration.
    Sugino IK; Rapista A; Sun Q; Wang J; Nunes CF; Cheewatrakoolpong N; Zarbin MA
    Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9598-609. PubMed ID: 22039244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular models and therapies for age-related macular degeneration.
    Forest DL; Johnson LV; Clegg DO
    Dis Model Mech; 2015 May; 8(5):421-7. PubMed ID: 26035859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preclinical Study of Human Induced Pluripotent Stem Cell-derived Retinal Pigment Epithelium Cell Sheets Transplantation].
    Kamao H
    Nippon Ganka Gakkai Zasshi; 2016 Nov; 120(11):754-63. PubMed ID: 30074740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stem cell-derived retinal pigment epithelium transplantation for treatment of retinal disease.
    Nommiste B; Fynes K; Tovell VE; Ramsden C; da Cruz L; Coffey P
    Prog Brain Res; 2017; 231():225-244. PubMed ID: 28554398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular regeneration strategies for macular degeneration: past, present and future.
    Chichagova V; Hallam D; Collin J; Zerti D; Dorgau B; Felemban M; Lako M; Steel DH
    Eye (Lond); 2018 May; 32(5):946-971. PubMed ID: 29503449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The identification of small molecules that stimulate retinal pigment epithelial cells: potential novel therapeutic options for treating retinopathies.
    Artero-Castro A; Popelka S; Jendelova P; Motlik J; Ardan T; Rodriguez Jimenez FJ; Erceg S
    Expert Opin Drug Discov; 2019 Feb; 14(2):169-177. PubMed ID: 30616395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stem cell-derived retinal pigment epithelium transplantation in age-related macular degeneration: recent advances and challenges.
    Kashani AH
    Curr Opin Ophthalmol; 2022 May; 33(3):211-218. PubMed ID: 35200164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiation of pluripotent stem cells into retinal pigmented epithelium.
    Croze RH; Clegg DO
    Dev Ophthalmol; 2014; 53():81-96. PubMed ID: 24732763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stem Cell Therapy in Nonneovascular Age-Related Macular Degeneration.
    Kashani AH
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(5):ORSFm1-9. PubMed ID: 27116669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunological factors in the pathogenesis and treatment of age-related macular degeneration.
    Kijlstra A; La Heij E; Hendrikse F
    Ocul Immunol Inflamm; 2005 Feb; 13(1):3-11. PubMed ID: 15804763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RPE transplantation and its role in retinal disease.
    da Cruz L; Chen FK; Ahmado A; Greenwood J; Coffey P
    Prog Retin Eye Res; 2007 Nov; 26(6):598-635. PubMed ID: 17920328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stem cells: a new paradigm for disease modeling and developing therapies for age-related macular degeneration.
    Melville H; Carpiniello M; Hollis K; Staffaroni A; Golestaneh N
    J Transl Med; 2013 Mar; 11():53. PubMed ID: 23452406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraocular microablation of choroidal tissue by a 308 nm AIDA excimer laser for RPE-transplantation in patients with age-related macular degeneration.
    Holz FG; Bindewald A; Schutt F; Specht H
    Biomed Tech (Berl); 2003 Apr; 48(4):82-5. PubMed ID: 12749285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stem cells as source for retinal pigment epithelium transplantation.
    Bertolotti E; Neri A; Camparini M; Macaluso C; Marigo V
    Prog Retin Eye Res; 2014 Sep; 42():130-44. PubMed ID: 24933042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.